BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11708914)

  • 1. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
    Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
    Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
    J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
    Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
    J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
    Ericson MD; Freeman KT; Schnell SM; Fleming KA; Haskell-Luevano C
    J Med Chem; 2017 Oct; 60(19):8103-8114. PubMed ID: 28813605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors.
    Kavarana MJ; Trivedi D; Cai M; Ying J; Hammer M; Cabello C; Grieco P; Han G; Hruby VJ
    J Med Chem; 2002 Jun; 45(12):2644-50. PubMed ID: 12036373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
    Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
    ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Macrocyclic Agouti-Related Protein/[Nle
    Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
    J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor.
    Haskell-Luevano C; Monck EK; Wan YP; Schentrup AM
    Peptides; 2000 May; 21(5):683-9. PubMed ID: 10876051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.